s-nitroso-n-acetylcysteine has been researched along with Hypertrophy, Left Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruni-Cardoso, A; Caceres, VM; de Carvalho, HF; de Souza, HP; Krieger, MH; Laurindo, FR; Moretti, AI; Spadari, RC; Wanschel, AC | 1 |
| de Souza, HP; dos Santos, L; Garcia, JA; Krieger, MH; Moura, AL; Ricardo, KF; Shishido, SM; Spadari-Bratfisch, RC; Wanschel, AC | 1 |
2 other study(ies) available for s-nitroso-n-acetylcysteine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Cardioprotective mechanism of S-nitroso-N-acetylcysteine via S-nitrosated betadrenoceptor-2 in the LDLr-/- mice.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Dyslipidemias; Endoplasmic Reticulum; Gene Expression Regulation; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Nitrogen; Oxidative Stress; Reactive Oxygen Species; Receptors, Adrenergic, beta-2; Receptors, LDL; Superoxides | 2014 |
S-nitroso-N-acetylcysteine (SNAC) prevents myocardial alterations in hypercholesterolemic LDL receptor knockout mice by antiinflammatory action.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Blood Pressure; CD40 Ligand; Gene Expression Regulation, Enzymologic; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Nitric Oxide Synthase Type III; Receptors, LDL | 2008 |